Skip to content
    Gaorong Capital logo

    Gaorong Capital

    Beijing, ChinaFounded 2014

    Gaorong Capital is a venture capital firm specializing in early and growth-stage investments, primarily in China. Their investment focus spans new consumption, new technology (including AI and frontier technologies), enterprise services, and healthcare sectors, with a strong emphasis on TMT. The firm positions itself as "China's Founders' Fund," aiming to be a strategic partner for entrepreneurs driving innovation and industry transformation.

    Deal activity decreased year-over-year (2 deals in the last 12 months vs 6 prior). Average disclosed round size is $221.6M (across 16 rounds with reported amounts).

    Find people at Gaorong Capital on Goldilocks AI

    Portfolio

    16

    Fund Size

    $4B

    Top Stage

    Growth

    Last 12 Mo

    2

    Team

    BY

    Bin Yue

    Partner

    JY

    Jiangtao Yu

    Managing Director

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    16 investments
    CompanyRoundAmountDate
    NNeolixSeries D$600MOct 2025
    MAI logoMAISeed$25MSep 2025
    PPulnovo MedicalSeries C$100MMar 2025
    HHashKey GroupGrowth$30MFeb 2025
    HHashKey GroupGrowth$30MFeb 2025
    AArnatar TherapeuticsSeries A$52MDec 2024
    Allink Biotherapeutics logoAllink BiotherapeuticsSeries A$42MNov 2024
    DDongchediGrowth$600MSep 2024
    Leonardo.Ai logoLeonardo.AiSeries B$31MDec 2023
    Nuro logoNuroSeries D$600MNov 2021
    ProfoundBio logoProfoundBioSeries A$55MJul 2021
    OPay logoOPaySeries B$120MNov 2019
    Nuro logoNuroGrowth$940MFeb 2019
    XTransfer logoXTransferSeries A$10MOct 2018
    PPinduoduoSeries B$110M
    SSironaxSeries B$200M

    Top Co-Investors

    Lilly Asia Ventures2 shared
    Yunqi Partners2 shared
    Hongshan1 shared
    KKR & Co.1 shared
    OrbiMed1 shared
    LYFE Capital1 shared
    K2VC1 shared
    UpHonest Capital1 shared

    Last updated: 15 April 2026